000 01175 a2200337 4500
005 20250516020420.0
264 0 _c20110211
008 201102s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/WNL.0b013e318204a3af
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThompson, Eric M
245 0 0 _aThe paradoxical effect of bevacizumab in the therapy of malignant gliomas.
_h[electronic resource]
260 _bNeurology
_cJan 2011
300 _a87-93 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aBevacizumab
650 0 4 _aBrain Neoplasms
_xdiagnosis
650 0 4 _aClinical Trials as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aGlioma
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Imaging
700 1 _aFrenkel, Eugene P
700 1 _aNeuwelt, Edward A
773 0 _tNeurology
_gvol. 76
_gno. 1
_gp. 87-93
856 4 0 _uhttps://doi.org/10.1212/WNL.0b013e318204a3af
_zAvailable from publisher's website
999 _c20491362
_d20491362